Involvement of circulating interleukin-6 and its receptor in the development of euthyroid side syndrome in patients with acute myocardial infarction

被引:41
作者
Kimura, T
Kanda, T
Kotajima, N
Kuwbara, A
Fukumura, Y
Kobayashi, I
机构
[1] Gunma Univ, Sch Med, Dept Gen Med, Maebashi, Gumma 3718511, Japan
[2] Gunma Univ, Sch Med, Clin Lab Ctr, Maebashi, Gumma 3718511, Japan
关键词
D O I
10.1530/eje.0.1430179
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In patients with acute myocardial infarction (AMI), low triiodothyronine (T-3) levels with normal or subnormal levels of thyrotropin (TSH), the euthyroid sick syndrome (ESS), have been reported, however. the mechanism of altered thyroid hormone metabolism is unknown. Recent reports have shown that interleukin-6 (IL-6) plays a key role in the pathogenesis of AMI and ESS. This preliminary study investigates the relationship between thyroid states and plasma levels of IL-6, the soluble IL-G receptor (sIL-6R), and the soluble transducing 130 KDa glycoprotein (sgp 130) in AMI. Design and methods: We measured the concentration of TSH, free T-3 (FT3), free thyroxine (FT4), IL-6, sIL-6R and sgp130 in plasma from 24 patients viith AMI and 20 normal controls. Results: All 24 AMI patients showed significantly lower concentrations of FT3 with normal or subnormal levels of TSH, and higher concentrations of IL-6 and sIL-6R than controls. IL-6 level was correlated with creatine phosphokinase (CPK) and FT3 levels but not with FT4 or TSH levels in patients with AMI. The time course of IL-6 and FT3 concentration seemed to be closely linked. sIL-6R level was correlated with CPK and sgp130 levels, but not with FT3, FT4 or TSH levels. FT4 level was correlated with sgpl30 level. Conclusion: Patients with AMI develop ESS through activation of IL-6 and its receptor system.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 37 条
[1]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[2]   RELATIONSHIP OF THE INCREASED SERUM INTERLEUKIN-6 CONCENTRATION TO CHANGES OF THYROID-FUNCTION IN NONTHYROIDAL ILLNESS [J].
BARTALENA, L ;
BROGIONI, S ;
GRASSO, L ;
VELLUZZI, F ;
MARTINO, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (04) :269-274
[3]   SOLUBLE CYTOKINE RECEPTORS AND THE LOW 3,5,3'-TRIIODOTHYRONINE SYNDROME IN PATIENTS WITH NONTHYROIDAL DISEASE [J].
BOELEN, A ;
SCHIPHORST, MCPT ;
WIERSINGA, WM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :971-976
[4]   Induced illness in interleukin-6 (IL-6) knock-out mice: A causal role of IL-6 in the development of the low 3,5,3'-triiodothyronine syndrome [J].
Boelen, A ;
Maas, MAW ;
Lowik, CWGM ;
Platvoet, MC ;
Wiersinga, WM .
ENDOCRINOLOGY, 1996, 137 (12) :5250-5254
[5]   THE ROLE OF CYTOKINES IN THE LIPOPOLYSACCHARIDE-INDUCED SICK EUTHYROID SYNDROME IN MICE [J].
BOELEN, A ;
PLATVOETTERSCHIPHORST, MC ;
BAKKER, O ;
WIERSINGA, WM .
JOURNAL OF ENDOCRINOLOGY, 1995, 146 (03) :475-483
[6]   ASSOCIATION BETWEEN SERUM INTERLEUKIN-6 AND SERUM 3,5,3'-TRIIODOTHYRONINE IN NONTHYROIDAL ILLNESS [J].
BOELEN, A ;
SCHIPHORST, MCP ;
WIERSINGA, WM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1695-1699
[7]  
BYSANI C, 1999, CIRCULATION, V99, P427
[8]   THYROID-FUNCTION IN NONTHYROIDAL ILLNESSES [J].
CHOPRA, IJ ;
HERSHMAN, JM ;
PARDRIDGE, WM ;
NICOLOFF, JT .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (06) :946-957
[9]   Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness [J].
Davies, PH ;
Black, EG ;
Sheppard, MC ;
Franklyn, JA .
CLINICAL ENDOCRINOLOGY, 1996, 44 (02) :199-205
[10]   Dangerous dogmas in medicine: The nonthyroidal illness syndrome [J].
De Groot, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :151-164